Latest News and Press Releases

Kneat's win of a global generics pharma leader showcases the versatility of its platform, which can be leveraged to deliver additional adjacent functions.

A large consumer packaged goods producer signed an agreement with Kneat to digitize validation in its life science division.

Leading European global therapeutics company more than 20,000 people selects Kneat to digitize its validation processes.

Medical devices and healthcare therapies maker signs 3-year Master Services Agreement with Kneat to streamline its computer systems validation processes.

ALTEN selects Kneat to digitize validation for itself and its customers.

Kneat achieves record results in growth and profitability, as third-quarter 2024 revenue and gross profit growth accelerate to 52% and 78% respectively,

Kneat signs a global and diverse medical devices manufacturer for digital validation.

Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024, and Host an Earnings Call on November 7

Kneat closed its previously announced bought deal, issuing 7,500,000 shares for gross proceeds to the Company of $35.6 million.

Another global pharmaceutical company selects Kneat to digitize its validation processes.